Trends in coronary risk factors in the WHO MONICA project

A Evans1, H Tolonen, H W Hense

  • 1Department of Epidemiology and Public Health, The Queen's University of Belfast, Mulhouse Building, Belfast BT12 6BJ, UK. a.evans@qub.ac.uk

Insights

The World Health Organization MONICA Project monitored coronary heart disease risk factors over ten years. While blood pressure and cholesterol trends improved, rising smoking rates in women and increasing body mass index (BMI) in both sexes are public health concerns.

Area of Science:

  • Cardiovascular Epidemiology
  • Public Health Surveillance
  • Preventive Cardiology

Background:

  • The World Health Organization (WHO) MONICA Project aimed to link coronary heart disease (CHD) event rates with classic risk factor trends.
  • Monitoring occurred over a decade (1979-1996) across 38 populations in 21 countries on four continents.

Purpose of the Study:

  • To assess trends in major coronary heart disease risk factors across diverse international populations.
  • To understand the relationship between changes in risk factors and CHD/stroke event rates.

Main Methods:

  • Utilized a standardized protocol for at least two to three independent surveys.
  • Employed random sampling within study populations, spaced throughout the ten-year period.
  • Monitored key risk factors including smoking, blood pressure, cholesterol, and body mass index (BMI).

Main Results:

  • Smoking rates declined in most men (35-64 years) but increased in most women.
  • Systolic blood pressure showed decreasing trends in the majority of centers for both sexes.
  • Cholesterol levels generally trended downwards, and body mass index (BMI) showed a significant increase in many male and female populations.

Conclusions:

  • It is feasible to monitor classic CHD risk factors in diverse populations over ten years using repeated surveys.
  • While overall risk factor trends are largely downwards, increasing smoking in women and rising BMI in both sexes present significant public health challenges.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...